Expert Interview
Discussing the data shown so far from 4D-150 in wAMD (Wet macular degeneration) and expectations for updated results to be presented at ARVO from 4D Molecular Therapeutics
Ticker(s): FDMTInstitution: Duke
- Assistant Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery at Duke.
- Manages 500 patients with geographic atrophy.
- Studies the biology, diagnosis and treatment of macular edema, and I am involved in basic laboratory science, ocular imaging analysis and clinical trials of new medications.
How many wAMD patients do you treats monthly?
Added By: wilson_adminWhat do you think of the data shown so far in wAMD from 4D-150?
Added By: wilson_adminWhat are your expectations for the updated data?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
